NY S02966 | 2021-2022 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 26 2021 - 25% progression, died in chamber
Action: 2021-06-03 - SUBSTITUTED BY A336A
Text: Latest bill text (Amended) [HTML]

Summary

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in 90 morphine milligram equivalents or higher per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in 90 morphine milligram equivalents or higher per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.

Sponsors


Roll Calls

2021-06-03 - Senate - Senate Floor Vote - Final Passage (Y: 51 N: 12 NV: 0 Abs: 0) [PASS]
2021-05-04 - Senate - Senate Finance Committee Vote (Y: 20 N: 3 NV: 0 Abs: 0) [PASS]
2021-04-20 - Senate - Senate Health Committee Vote (Y: 11 N: 4 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2021-06-03SenateSUBSTITUTED BY A336A
2021-05-10SenateADVANCED TO THIRD READING
2021-05-05Senate2ND REPORT CAL.
2021-05-04Senate1ST REPORT CAL.904
2021-04-19SenatePRINT NUMBER 2966A
2021-04-19SenateAMEND AND RECOMMIT TO FINANCE
2021-04-19SenateREPORTED AND COMMITTED TO FINANCE
2021-01-26SenateREFERRED TO HEALTH

Same As/Similar To

A00336 (Same As) 2021-12-30 - signed chap.803

New York State Sources


Bill Comments

feedback